| AFMD Market Cap History Table | ||||||||||||||||||
Below is a table of the AFMD market cap history going back to 9/12/2014:
Also see: AFMD Shares Outstanding History and AFMD YTD Return |
AFMD Market Cap History — Affimed N.V. Capitalization Over Time
As of 12/30/2020 Affimed N.V. has a market cap of 588.74 million. Investors often follow the AFMD market cap history to compare the size of the company over time.
This page shows AFMD market capitalization trends over time, with 8 market cap datapoints presented, dating back to 9/12/2014.
| AFMD Market Cap History Chart | ||||||||||||||||||||||||
AFMD Historical Market Cap: +27.59% CAGR 
Mouse over chart for data details
| ||||||||||||||||||||||||
| AFMD Stock Price Chart |
| About Affimed N.V. |
| Affimed is a clinical-stage immuno-oncology company focused on discovering and developing targeted cancer immunotherapies. Co.'s main candidate, AFM13, is an innate cell engager (ICE®) designed for the treatment of certain CD30-positive malignancies, including for both Hodgkin lymphoma and certain non-Hodgkin lymphomas. Co.'s second candidate, AFM24, is designed to address limitations, such as toxicities or treatment resistance, associated with existing therapeutic anti-epidermal growth factor receptor monoclonal antibodies. Co.'s third wholly-owned ICE® molecule, AFM28, was developed from its ROCK® platform and is designed to bind to CD123, an established target in myeloid malignancies. We show 8 historical shares outstanding datapoints in our AFMD shares outstanding history coverage, used to compute AFMD market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AFMD market cap history over the course of time is important for investors interested in comparing AFMD's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AFMD versus a peer is one thing; comparing AFMD market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AFMD can fluctuate over the course of history. With this page we aim to empower investors researching AFMD by allowing them to research the AFMD market cap history. |
| AFMD Current Stock Quote |
Quotes delayed 20 minutes  Free AFMD Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| AFMD Share Performance |
| Market Cap Peers |
| Affimed N.V. (AFMD) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AFRI Market Cap History AFTR Market Cap History AFYA Market Cap History AGAC Market Cap History AGCB Market Cap History AGGR Market Cap History AGIL Market Cap History AGMH Market Cap History AGNG Market Cap History AHAC Market Cap History More Miscellaneous companies » |
AFMD Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
